Rick Simpson Oil (RSO) in Jefferson County, Iowa: The Complete Guide by OilWell Cannabis

ABOUT RICK SIMPSON AND TRADITIONAL RICK SIMPSON OIL

Who is Rick Simpson

Rick Simpson was born in 1949 in Amherst, Nova Scotia, Canada. He wasn’t a doctor, scientist, or medical professional—he was a power engineer and maintenance worker, a blue-collar tradesman whose path into cannabis advocacy began not with research but with personal suffering and a deep distrust of the medical system that failed him. Here in Jefferson County, Iowa, we know what it means when the medical system falls short—when you’re facing a two-hour drive to University of Iowa Hospitals in Iowa City just to see a specialist, or when your local clinic in Fairfield simply doesn’t have the resources to manage complex chronic conditions.

In 1997, while working at a hospital in Moncton, New Brunswick, Simpson fell from scaffolding and suffered a serious head injury. The aftermath included persistent tinnitus, dizziness, and post-concussion symptoms that conventional medicine couldn’t resolve. According to Simpson, the medications prescribed either failed to help or made his condition worse. He reported that cannabis provided more relief than anything his doctors offered, but when he asked his physician to support or prescribe cannabis, the request was refused. That experience resonates deeply across Jefferson County—where many of us have asked our doctors about cannabis alternatives only to be met with dismissal or uncertainty, especially given Iowa’s restrictive medical program.

Simpson’s interest in concentrated cannabis oil deepened after he learned about a 1974 study funded by the National Institute of Health and conducted at the Medical College of Virginia, in which THC was reported to slow or shrink tumors in mice. That study—originally intended to demonstrate harm—became a foundational reference point in Simpson’s later advocacy, even though its findings were never replicated in controlled human cancer trials.

The pivotal moment came in 2003. Simpson reported that three bumps on his arm were diagnosed as basal cell carcinoma. Rather than pursuing conventional treatment, he applied concentrated cannabis oil directly to the lesions, covered them with bandages, and waited. According to his account, the bumps disappeared within four days. No independent medical verification of this outcome has been published, and no biopsy confirmation or clinical follow-up has been documented in any peer-reviewed source. Nevertheless, this personal experience became the origin story of Rick Simpson Oil.

Important context: Simpson’s account is presented here as his personal testimony. The absence of clinical documentation means these events cannot be evaluated as medical evidence. They are, however, historically significant as the catalyst for a global movement—one that has reached even our quiet corners of Jefferson County, where word-of-mouth about RSO has spread through farming communities, veterans’ groups, and cancer support networks meeting at the Jefferson County Health Center or gathering at local churches.

The crusade — spreading the oil

After his 2003 experience, Simpson committed himself to producing and distributing concentrated cannabis oil from his property in Maccan, Nova Scotia. He gave it away for free to cancer patients and others, charging nothing. By his account, he helped dozens with conditions including cancer, chronic pain, diabetes, infections, glaucoma, arthritis, depression, insomnia, and more.

Simpson’s story reached a global audience through the 2005 documentary Run From The Cure, directed by Christian Laurette. It became one of the most widely shared cannabis advocacy films, and for many in Jefferson County—especially those without easy access to medical specialists—it was their introduction to concentrated cannabis oil as medicine.

But Simpson’s advocacy brought him into direct conflict with Canadian law. The RCMP raided his property in 2005 and 2009, charging him with cultivation, possession, and trafficking. Facing continued legal pressure, Simpson eventually left Canada for Europe, continuing his advocacy from Croatia and the Netherlands.

In 2012, he published Phoenix Tears: The Rick Simpson Story and maintained phoenixtears.ca as his advocacy platform. Throughout his career, Simpson maintained that cannabis oil could cure cancer and many other diseases, framing his work as a fight against institutional corruption.

Important context: Simpson’s conspiratorial framing is noted here without endorsement. It reflects a worldview shared by many in early cannabis advocacy and is relevant to understanding RSO’s cultural significance. Here in Jefferson County, where trust in institutions varies—some still remember when the Farm Crisis shook faith in government programs—this perspective resonates even if the evidence doesn’t support all the claims.

The traditional RSO protocol — Simpson’s 60-gram, 90-day regimen

Simpson’s core recommendation was consuming 60 grams of concentrated cannabis oil over approximately 90 days. For Jefferson County residents managing chronic conditions while working demanding jobs—whether on farms, in manufacturing, or at the local schools—this protocol represents a significant time and lifestyle commitment.

Goal

Consume 60 grams of concentrated, high-THC cannabis oil over roughly 90 days. Simpson considered this the minimum for serious cancer treatment.

Titration schedule

• Week 1: Begin with a dose the size of half a grain of rice—about 10-15mg of oil—three times daily. Total daily intake: 30-45mg. For someone in Jefferson County working a 12-hour shift at the Cargill plant or during harvest season, this initial phase requires careful timing around work responsibilities.

• Weeks 2-5: Double the dose every four days to build THC tolerance gradually. By week five, target approximately 1 gram (1,000mg) per day, divided into three doses.

• Weeks 5-12: Maintain 1 gram daily until all 60 grams are consumed.

Administration methods

• Primary method—oral: Place under tongue or swallow. For systemic conditions, this was Simpson’s main recommendation.
• Secondary method—topical: Apply directly to skin lesions, cover with bandage, change every 3-4 days. Combined with oral dosing for skin cancers.
• Not recommended—inhaling: Simpson acknowledged inhalation for immediate symptom relief but maintained oral delivery was essential for therapeutic exposure.

Tolerance and psychoactive effects

Simpson claimed patients develop THC tolerance within 3-4 weeks, considering euphoria a minor temporary side effect. He recommended initial nighttime dosing and avoiding driving during titration. For Jefferson County residents who commute on Highway 34 or rural gravel roads, this impairment risk is a serious practical consideration—especially during planting and harvest seasons when farm equipment shares the roads.

Post-protocol maintenance

After completing 60 grams, Simpson recommended 1-2 grams monthly indefinitely for long-term health and cancer prevention.

Important context for evaluating this protocol

• No controlled trial validation. There are no published randomized controlled trials, cohort studies, or well-documented case series evaluating this specific protocol for any cancer type or condition.
• Assumes crude, unstandardized material. The 60-gram quantity assumes single-strain, THC-dominant extract with no standardized potency.
• Very high THC exposure. At peak dosing (1 gram daily of 60-90% THC oil), patients consume 600-900mg of delta-9 THC daily—far exceeding anything studied clinically. For context, FDA-approved dronabinol is typically dosed at 2.5-20mg daily.
• Real risks at these doses. Consuming 600-900mg of THC daily carries serious risks: severe intoxication, impairment, anxiety, panic, tachycardia, hypotension, and cannabis use disorder.
• Oncology context. Patients with active cancer are medically complex. Using unregulated, unstandardized cannabis oil as primary treatment—potentially in place of proven therapies—introduces harm beyond the oil itself.

For Jefferson County residents considering this protocol, it’s crucial to understand these risks, especially given limited local oncological support resources.

What is traditional Rick Simpson Oil — the product

Traditional RSO was defined by Simpson’s method, not lab specifications:

Source material

Simpson used high-THC, indica-dominant cannabis strains with no standardization. For Jefferson County residents familiar with Iowa’s agricultural heritage, this variability is like buying seed corn without knowing the hybrid—every batch is different.

Extraction solvent

Simpson originally used naphtha (petroleum-based lighter fluid) or 99% isopropyl alcohol. Neither is food-grade. Naphtha may contain benzene, toluene, and other toxic compounds. Incomplete solvent purging leaves potentially harmful residues.

Extraction process

1. Place dried cannabis in a bucket
2. Cover with solvent and agitate to dissolve cannabinoids
3. Filter through cheesecloth into collection vessel
4. Repeat with fresh solvent
5. Evaporate solvent in rice cooker at relatively low heat
6. Transfer thick, dark oil to syringes

This process, while effective at extracting cannabinoids, destroys terpenes and carries significant safety risks—especially for Jefferson County residents who might consider DIY extraction in home kitchens without proper ventilation or fire safety equipment.

Appearance and physical characteristics

Traditional RSO is nearly black, thick, tar-like, with strong cannabis odor and possible solvent-residual smell. The consistency is sticky and difficult to handle.

Cannabinoid profile

• Primarily decarboxylated delta-9 THC (60-90% estimated)
• Naturally occurring minor cannabinoids at uncontrolled ratios
• No ratio control—profile entirely determined by source plant genetics

Terpene content

Minimal to none. The solvent extraction and high-heat evaporation process strips terpenes, leaving a cannabinoid-only product despite being derived from terpene-rich plant material.

Standardization and testing

None. Every batch differed based on starting material, growing conditions, solvent purity, extraction technique, and evaporation parameters. No Certificate of Analysis, no cannabinoid quantification, no contaminant screening.

Residual solvent risk

This is one of the most significant safety concerns. Naphtha is a petroleum hydrocarbon mixture that may contain carcinogens. Incomplete purging is difficult to verify without lab testing. Modern extraction uses food-grade ethanol or supercritical CO₂ specifically to address this problem.

For Jefferson County residents who value the agricultural purity of our local food systems, this solvent risk should be a major concern when considering any cannabis extract.

Simpson’s claims vs. the evidence record

Simpson claimed RSO could cure cancer and numerous other diseases. He was adamant and consistent throughout his advocacy career. But here in Jefferson County, where we’ve seen too many neighbors suffer despite trying every available treatment, we owe it to ourselves to examine these claims against actual evidence.

What Simpson was not

Simpson was not a scientist, physician, pharmacologist, or researcher. He had no formal training in medicine, oncology, or clinical research. He never designed, conducted, funded, or published a clinical trial. His evidence base consisted entirely of personal experience, self-reported patient outcomes, and testimonials gathered informally—with no controls, no independent verification, no imaging confirmation, no long-term follow-up, and no blinding.

What the preclinical literature shows

The preclinical cannabinoid-cancer literature does exist and is scientifically interesting:

• In vitro studies show THC and CBD can induce apoptosis (programmed cell death), inhibit proliferation, and reduce angiogenesis in certain cancer cell lines
• Animal models show some tumor-growth inhibition in mice and rats treated with cannabinoids

These findings have generated legitimate scientific interest and ongoing research.

What the preclinical literature does not show

• These findings have not translated into proven human cancer cures. The gap between in vitro/animal results and human clinical outcomes is vast.
• No human clinical trial has demonstrated that RSO or any cannabis oil preparation cures cancer.
• Several small human trials of cannabinoids in cancer contexts (particularly glioblastoma) have been exploratory and have not produced results supporting cancer-cure claims .

Institutional positions

• U.S. National Cancer Institute (NCI): Acknowledges cannabinoids have been studied for potential anticancer effects in lab and animal models but does not endorse cannabis or cannabis oil as a cancer treatment .
• FDA: Has not approved any cannabis plant product for cancer treatment. Only FDA-approved cannabinoid products are Epidiolex (CBD) for certain seizure disorders and dronabinol/nabilone (synthetic THC analogues) for chemotherapy-related nausea and AIDS-related wasting [1].
• Health Canada: Has never approved RSO or cannabis oil as a cancer cure.
• NCCIH: States strongest cannabinoid evidence is for rare epilepsies, chemotherapy-related nausea/vomiting, and appetite-related indications in HIV/AIDS—not cancer cure [1].

What Simpson got right

Simpson drew attention to cannabinoids as a serious biomedical research area when the world was ignoring it. His advocacy helped create the political, cultural, and social conditions for the legal cannabis industry and cannabinoid research infrastructure that exists today. He was among the first to bring concentrated cannabis oil to widespread public awareness, and the term RSO remains the most recognized name for full-spectrum cannabis extract.

What he overstated

The leap from preclinical signals to cancer cure was not supported by human evidence when Simpson made it, and it’s not supported now. Encouraging patients—particularly cancer patients—to rely on RSO as primary treatment in place of proven oncologic therapies carries genuine harm potential. Delayed or foregone treatment for treatable cancers is a documented concern in alternative medicine literature.

For our Jefferson County community, where cancer touches so many families and where access to oncology specialists requires travel to Iowa City or Cedar Rapids, this is not an abstract concern. It’s about protecting our neighbors from making decisions that could cost them precious time.

The legacy of Rick Simpson and the evolution of modern RSO

The term RSO is now used broadly and loosely across the legal cannabis industry. Many products labeled as RSO bear little resemblance to what Simpson originally made. In dispensaries today, RSO can refer to almost any full-spectrum cannabis extract sold in a syringe format, regardless of extraction method, cannabinoid profile, terpene content, or intended use. The term has become generic .

Simpson himself has been critical of commercial products that use the RSO name while departing significantly from his original method and philosophy. He believed in a DIY, free-access model where anyone could grow cannabis, extract oil, and treat themselves without corporate or governmental intermediaries. The modern cannabis industry has commercialized, standardized, and regulated what Simpson distributed for free.

Whether that evolution represents improvement (quality control, lab testing, dosing precision) or betrayal (profit extraction, regulatory gatekeeping) depends on perspective. What is not in dispute is that modern RSO has evolved substantially, and those changes are directly relevant to Jefferson County residents seeking safe, legal access.

Traditional RSO vs. modern formulated RSO

The following table summarizes key differences between traditional RSO and OilWell’s modern approach—critical information for Jefferson County consumers navigating an increasingly complex market.

Dimension	Traditional RSO	OilWell formulated RSO
Source material	Single high-THC indica strain	Multi-cannabinoid blend
Extraction method	Naphtha or isopropyl alcohol	Food-grade ethanol/CO₂
Cannabinoid profile	THC-dominant, uncontrolled	Seven defined cannabinoids
Terpene content	Destroyed by heat	Live terpenes at 5%
Standardization	None—every batch different	Lab-tested with mg/mL targets
Lab testing	Not performed	Full panel COA available
Residual solvents	Significant risk	Controlled and tested
Dosing precision	Approximate syringe	Measured 553mg/mL
Product formats	Single thick oil only	Sublingual oil + vape
THCa preservation	No—fully decarboxylated	Yes—1,500mg separate ingredient
Evidence approach	Anecdotal testimony	Research-backed, evidence-weighted

Why OilWell’s formulas diverge from traditional RSO

OilWell’s formulations depart from traditional RSO in deliberate, evidence-motivated ways:

• Multi-cannabinoid approach: Traditional RSO relied on whatever single strain was available. OilWell’s seven-cannabinoid formula reflects entourage-effect literature suggesting potential benefit from cannabinoid diversity [20][29].

• Terpene preservation: Traditional RSO had essentially no terpene content. OilWell includes live terpenes at 5% because terpene bioactivity is plausible and supported at preclinical level [20]-[28].

• THCa as separate ingredient: Traditional RSO fully decarboxylated everything. OilWell preserves 1,500mg THCa as a distinct ingredient because THCa literature suggests non-psychoactive bioactivity lost during conversion [12].

• Reduced delta-9 THC dominance: Traditional RSO was 60-90% delta-9 THC. OilWell uses only 90mg delta-9 THC while distributing cannabinoid content across CBD, CBG, delta-8, CBN, and CBC—reflecting broader cannabinoid research.

• Product format innovation: Simpson envisioned only oral oil. OilWell offers both sublingual oil and vape cartridge, acknowledging different delivery routes have different pharmacokinetic profiles [14].

Solvent safety and extraction evolution

Traditional RSO production used naphtha or isopropyl alcohol—neither food-grade. Naphtha is a petroleum hydrocarbon mixture that may contain benzene, toluene, and other toxins. Incomplete purging leaves harmful residues.

Modern cannabis extraction uses food-grade ethanol or supercritical CO₂, allowing more complete solvent removal with finished products tested for residual solvents via headspace gas chromatography.

For Jefferson County residents who value the agricultural purity of our local food systems—who buy sweet corn from the Fairfield Farmers Market and trust the quality of locally-raised beef—this solvent risk should be a major concern. OilWell’s solvent-free approach addresses this directly.

The decarboxylation question

Traditional RSO was fully decarboxylated. The heat involved in evaporating solvent (60-80°C for naphtha, 82°C for isopropyl alcohol) converted all THCa to delta-9 THC.

OilWell’s sublingual formula deliberately preserves 1,500mg THAa as a distinct ingredient. This is an intentional choice informed by THCa evidence showing potential non-psychoactive bioactivity via COX-2 inhibition and PPARγ agonism [12].

For Jefferson County residents who need to work, drive, or operate farm equipment, this distinction is crucial. The same product can function as non-psychoactive anti-inflammatory (used raw) or full-potency psychoactive medicine (after home decarboxylation).

Terpene loss in traditional RSO

Terpenes volatilize at relatively low temperatures (21-157°C). Traditional RSO’s solvent extraction and high-heat evaporation destroyed terpenes, leaving a cannabinoid-only product despite being derived from terpene-rich plant material.

OilWell’s formulas specify live terpenes at 5% with a defined seven-terpene profile: limonene, myrcene, caryophyllene, pinene, linalool, humulene, and terpinolene. Each terpene has its own evidence profile in the GENERAL KNOWLEDGE section.

Evidence standards then and now

Rick Simpson operated in a pre-legalization, pre-lab-testing era. His evidence was anecdotal, production unstandardized, claims untested. This document applies a formal evidence hierarchy: human clinical evidence first, then systematic reviews, institutional summaries, then preclinical literature [1]-[29].

Every compound-level claim is tied to specific peer-reviewed sources with evidence strength clearly labeled. OilWell’s approach honors RSO’s historical origin while committing to modern cannabinoid science standards—exactly what Jefferson County residents deserve when making health decisions.

Simpson’s protocol vs. modern dosing considerations

Simpson’s 60-gram/90-day protocol was designed around crude, single-strain, THC-dominant extract. OilWell’s products require their own dosing approach:

• Cannabinoid concentration: OilWell’s sublingual formula delivers 553mg total cannabinoids per mL across seven defined compounds.
• Cannabinoid ratios: Completely different pharmacologic profile—distributed across CBD, CBG, delta-8, CBN, CBC, not just delta-9 THC.
• Delta-9 THC exposure: OilWell’s formula contains only 90mg delta-9 THC in the entire 30mL bottle (3mg/mL) vs. Simpson’s 600-900mg daily.

For Jefferson County residents working with their physicians at Jefferson County Health Center or seeking guidance from providers in Ottumwa or Burlington, it’s crucial to understand that OilWell’s product dosing should be developed independently of Simpson’s protocol, informed by per-compound evidence and responsible titration principles.

References for this section

RS1. Simpson R. Phoenix Tears: The Rick Simpson Story. Simpson RamaDur LLC; 2012.

RS2. Laurette C, director. Run From The Cure: The Rick Simpson Story . 2005.

RS3. Simpson R. Instructions and dosing information published on phoenixtears.ca.

RS4. Velasco G, Sánchez C, Guzmán M. Towards the use of cannabinoids as antitumour agents. Nat Rev Cancer. 2012;12(6):436-444.

RS5. Guzmán M, Duarte MJ, Blázquez C, et al. A pilot clinical study of delta-9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme. Br J Cancer. 2006;95(2):197-203.

RS6. National Cancer Institute. Cannabis and Cannabinoids (PDQ) — Health Professional Version. NIH/NCI. Updated 2024.

ABOUT OILWELL CANNABIS AND THE OILWELL RSO FORMULA

The origin of OilWell Cannabis

OilWell Cannabis was founded by Colin Valencia in Houston, Texas. While Houston might seem a world away from Jefferson County’s cornfields and quiet country roads, the story that built this company speaks directly to challenges we face here in rural Iowa.

Colin grew up in McAllen, Texas—right across the river from Reynosa, Mexico, in the Borderplex, one of the most economically challenged and dangerous regions along the U.S.-Mexico border. The McAllen-Reynosa area is a place of contrasts—vibrant culture alongside deep poverty and cartel violence. Many of Colin’s best friends have been killed or are in prison because of the associated dangers. He faced every form of violence imaginable, both in the streets and across the border. By sixteen, he had to leave home for good.

Despite the dangers, Colin chose cannabis over darker paths. He grew up in the traditional cannabis world long before legalization, learning the plant intimately while operating in the shadows. Over time, he transitioned from those early, risky ventures to creating a legal, legitimate business—proving that someone from the hardest circumstances could build something with integrity.

Colin later became a formally trained software engineer and did custom development work for Baylor College of Medicine, one of the most prestigious medical institutions. That combination—deep cannabis plant knowledge plus medical-grade technical precision—defines OilWell’s approach and should matter to Jefferson County residents who expect both agricultural wisdom and scientific rigor.

The company’s origin story begins with a dog named Bentley. Bentley was more than a pet—he was family. When Bentley fell seriously ill, veterinarians delivered the verdict no pet owner wants to hear: euthanasia was the only humane option. Bentley was paralyzed in his back legs. They said pain medications would destroy his internal organs, causing more suffering. The choice was painful prolonged decline or immediate mercy killing.

But giving up wasn’t an option. In a desperate search for alternatives, Colin learned about CBD through a question that changed everything: “You’ve moved how many tons of weed and you’ve never heard of CBD?” Colin had cannabis experience—but it was recreational. He’d never explored therapeutic applications.

Determined to save Bentley, Colin created CBD golden paste. It wasn’t a cure, but it was hope—and that hope delivered something veterinary medicine said was impossible: Bentley got up, walked over, and brought his ball to play. From paralyzed and facing euthanasia to fetching his ball. This was not placebo effect—dogs don’t respond to placebo. This was cannabinoid medicine doing what pharmaceuticals could not.

Bentley lived another ten years, passing naturally at age twenty. During those years, Colin developed specialized formulas for every age-related condition Bentley faced. Neurodegeneration led him to understand CBG’s neuroprotective properties and THCa’s PPARγ agonism for brain cell protection. Dementia led him to CBC’s role in neurogenesis. Glaucoma led him to THC’s CB1 agonism for intraocular pressure reduction. Crippling arthritis led him to develop multi-pathway anti-inflammatory approaches using CBD, CBG, THCa, and beta-caryophyllene working through different receptor systems simultaneously.

Single cannabinoids were not enough. Bentley’s evolving conditions required multi-cannabinoid synergy. Pharmaceutical precision mattered—Bentley’s life depended on formula accuracy, not guesswork. For Jefferson County pet owners who’ve watched beloved animals suffer, this story hits home. We’ve all had that vet conversation at the Fairfield Animal Hospital or the clinic in Batavia. Bentley’s journey was Colin’s entry into cannabis beyond getting high—it became a mission to create real solutions that alleviate pain and suffering, for pets and people.

Colin also knows pharmaceutical dependence personally. He struggled with PTSD and benzodiazepine addiction. When he decided to break free from Xanax, he did it cold turkey—a feat notoriously difficult and dangerous—using the cannabinoid knowledge he developed keeping Bentley alive. The Peace Gummies formula was created during midnight experiments while fighting through benzo withdrawal. Colin personally uses the vape form to manage his insomnia and severe PTSD. This is not theoretical knowledge. He lived what RSO patients live: desperation for relief, failed pharmaceuticals, discovery that cannabinoids work when pills do not.

Over time, the therapeutic benefits Colin discovered through saving Bentley became the core of his work. He developed formulas that doctors use for Crohn’s disease, IBS, ulcerative colitis, PTSD, benzo addiction, and insomnia. His focus has always been making cannabis accessible and effective for everyone, including vegans, diabetics, and those with specific health needs.

ABC13 KTRK Houston—Houston’s number-one news source—featured Colin and OilWell Cannabis in seven comprehensive news segments spanning 2019 to 2023, covering Texas marijuana law, Delta-8 legal analysis, COVID-19 community health leadership, criminal justice reform, and cannabis business pioneering. Colin was repeatedly selected as the primary industry expert for cannabis policy and product coverage in America’s fourth-largest city.

Colin’s quote from the first ABC13 feature in September 2019 captures OilWell’s philosophy: “I’m not trying to sell people snake oil. I’m not trying to sell people hope. But there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.”

Today, OilWell Cannabis operates from Montrose, Houston, Texas (810 Richmond Avenue, Houston, TX 77006). The company has been operating since 2019, generates approximately one million dollars in annual revenue, maintains a near-5.0 Google rating, and is Texas DSHS licensed. All artwork, formulations, and packaging are created in-house in Houston, using only OilWell’s own recipes and ideas. Colin brings Houston grit, McAllen roots, and a builder’s mindset, but the posture stays simple: make products with intent, answer directly, and never pretend cannabis is right for everyone.

For Jefferson County residents, this Texas origin story matters because it demonstrates that OilWell isn’t a fly-by-night internet brand—it’s a real, licensed, successful business with media-verified credibility that can ship directly to your doorstep in Fairfield, Libertyville, Packwood, or anywhere else in the county.

The OilWell RSO philosophy

OilWell’s RSO is not traditional Rick Simpson Oil. It’s a formulated, multi-cannabinoid product informed by the RSO tradition but departing from it in deliberate, evidence-motivated ways designed to solve problems that limited Rick Simpson’s original vision.

Four core principles define OilWell’s approach:

1. Accessibility over gatekeeping. No medical card required. Anyone age 21+ can purchase. OilWell ships nationwide and internationally. For Jefferson County residents who don’t qualify for Iowa’s extremely restrictive medical cannabis program—or who live hours from the nearest dispensary in Davenport or Council Bluffs—this accessibility is transformative.

2. Patient-controlled potency. THCa is sold in its acidic, non-psychoactive form. The customer decides whether to use it raw for non-psychoactive benefits or decarboxylate it into delta-9 THC for full psychoactive potency. For Jefferson County farmers who need to operate equipment at dawn or residents who drive Iowa’s rural highways daily, having a non-psychoactive daytime option is invaluable.

3. Open-source formulas. OilWell publishes complete formulas publicly—every cannabinoid, every milligram amount, every percentage—so anyone who cannot afford the product can source ingredients and make their own version. This matters in Jefferson County, where median household income is below the state average and healthcare costs strain family budgets.

4. Evidence-informed, not evidence-overstating. The GENERAL KNOWLEDGE section represents OilWell’s commitment to honest education about what science actually says. Simpson operated without peer-reviewed literature; OilWell has that access and uses it to distinguish between well-supported, emerging, and overstated claims.

Farm Bill compliance and the THCa legal framework

The 2018 Farm Bill legalized hemp and hemp-derived products containing less than 0.3% delta-9 THC by dry weight at the federal level. This legal framework is the foundation of OilWell’s RSO product design.

OilWell’s RSO Sublingual Oil contains only 90 milligrams of delta-9 THC in the entire 30 mL bottle—3 milligrams per milliliter—well under the 0.3% threshold. All cannabinoids are hemp-derived. The product is legal under federal law.

THCa is the acidic, non-psychoactive precursor to delta-9 THC. It is not itself delta-9 THC, making it Farm Bill compliant at point of sale. The customer can legally decarboxylate THCa into delta-9 THC at home by heating the oil at 260°F (125°C) for 45-60 minutes.

This converts 1,500 milligrams of THCa into approximately 1,315 milligrams of delta-9 THC. Combined with the existing 90 milligrams, this yields approximately 1,405 milligrams of total delta-9 THC—giving the product psychoactive potency comparable to traditional illegal RSO, entirely at the customer’s discretion after purchase.

For Jefferson County residents, this means legal purchase, possession, and transport. You can order from OilWell and have it shipped to your home in Batavia, Coppock, or anywhere in the county without violating federal law. Iowa state law aligns with the Farm Bill regarding hemp-derived products, though customers should stay informed about any local ordinances.

Important legal notice: THCa converts to delta-9 THC when heated. Customers are responsible for understanding and complying with local laws. OilWell ships with full documentation, Certificates of Analysis, and receipts. International customers accept all customs and legal risk.

Open-source formulas — why OilWell publishes everything

OilWell publishes complete RSO formulas publicly—every cannabinoid, every milligram amount, every percentage—so anyone who cannot afford the product can source ingredients and make their own. This is a direct echo of Rick Simpson’s original ethos.

For Jefferson County residents facing economic pressure—from medical bills, property taxes, or the challenges of farming in today’s market—this open-source approach means you’re not shut out. If $129.99 for the sublingual oil or $49.99 for the vape cartridge strains your budget, you have the recipe.

This philosophy didn’t start with RSO—it started with Bentley. On the About Us page, Colin published the actual CBD golden paste recipe that saved Bentley’s life:

CBD golden paste recipe for pets — the original open-source formula

Ingredients:

• 1/2 cup organic turmeric powder
• 1 cup water
• 1/3 cup coconut oil (unrefined, organic)
• 1-2 teaspoons freshly ground black pepper (important for absorption)
• CBD oil (dosage depends on pet size; consult veterinarian)

Instructions:

1. Mix turmeric and water in saucepan over low heat, stirring continuously until thick paste forms (7-10 minutes)
2. Add coconut oil and pepper, stir until thoroughly mixed
3. Cool and store in jar with lid (refrigerate up to two weeks)
4. Add CBD oil before serving, adjusting dosage based on weight and needs

Serving suggestion: Mix small amount with pet’s food once or twice daily. Monitor pet and consult veterinarian with concerns.

This recipe—published for free—demonstrates that open-source behavior is foundational to OilWell, not a marketing strategy. For Jefferson County pet owners who’ve faced those impossible vet conversations, this is immediately useful content.

The decarboxylation choice — patient-controlled potency

Traditional RSO was always fully decarboxylated. OilWell’s sublingual formula contains 1,500mg THCa, creating three distinct usage options:

Option 1 — Raw, no heat: All 1,500mg stays as THCa—completely non-psychoactive. For Jefferson County residents who operate tractors, work at the Siemens plant in Fairfield, or drive school bus routes, this provides anti-inflammatory benefits without impairment.

Option 2 — Fully activated, home decarboxylation: Heating at 260°F for 45-60 minutes converts 1,500mg THCa to ~1,315mg delta-9 THC. Combined with existing 90mg, this yields ~1,405mg total delta-9 THC—comparable to traditional illegal RSO, 100% legally, because decarboxylation occurs after purchase.

Option 3 — Vape, auto-decarboxylation: The RSO Vape Cartridge vaporizes at 400-450°F, instantly converting THCa to delta-9 THC with each puff.

This design puts potency decision entirely in the customer’s hands—aligning with Rick Simpson’s principle that patients should control their medicine, but implementing it through actual chemistry rather than rhetoric.

Solvent-free production

OilWell’s RSO is not an extraction product. It’s a formulated blend of individual cannabinoid distillates and isolates combined in a controlled production environment. No naphtha, no isopropyl alcohol, no butane, no extraction solvents.

This eliminates the residual solvent risk that is one of the most significant safety concerns with traditional RSO production.

The product uses organic MCT oil as the carrier base—food-grade lipid that facilitates sublingual absorption and provides neutral taste, a significant improvement over traditional RSO’s tar-like consistency and solvent-residual odor.

Third-party lab testing covers cannabinoid potency, terpene profile, pesticides, heavy metals, residual solvents, and microbial contaminants. Certificates of Analysis are available on request and through the OilWell website.

For Jefferson County residents who care about what goes into their bodies—who trust the purity of local honey from MUMS the word apiaries and organic produce from the Fairfield Farmers Market—this testing transparency matters.

The broader OilWell product portfolio

Beyond RSO, OilWell produces:

Asshole Peach — OilWell’s most popular product. Carefully formulated for euphoric, long-lasting sensation, particularly favored by veterans for PTSD and pain relief.

Peace Gummies — Developed from Colin’s personal benzo withdrawal experience. Helps manage insomnia and severe PTSD. Available in vape form for quick relief.

Custom creations — OilWell designs tailored products for specific cannabinoid ratios, delivery formats, or health circumstances, including formulations for vegans, diabetics, and those with specific dietary needs.

For Jefferson County veterans—who make up a significant portion of our community after service in Vietnam, Iraq, Afghanistan, and other conflicts—these veteran-focused formulations are particularly relevant.

Two product formats

OilWell offers the RSO formula in two delivery formats:

RSO Sublingual Oil — $129.99

• 30mL bottle, 16,590mg total cannabinoids (553mg/mL)
• Seven cannabinoids: CBD 4,500mg, CBG 3,000mg, delta-8 THC 6,000mg, THCa 1,500mg, delta-9 THC 90mg, CBN 750mg, CBC 750mg
• Live terpenes at 5%
• Organic MCT oil base
• Graduated dropper (0.1mL increments)
• Onset: 15-45 minutes
• Duration: 4-6 hours
• Bioavailability: 13-19%
• 40-60 doses per bottle

RSO Vape Cartridge — $49.99

• 1-gram cartridge, 900mg+ total cannabinoids
• Same six-cannabinoid ratio (no separate delta-9 THC listing—auto-decarbs at vaping temperature)
• Live terpenes at 5%+
• 510-thread universal battery compatibility
• Onset: 1-2 minutes (fastest delivery)
• Duration: 2-4 hours
• Bioavailability: 10-35%

When to use each format

Use case	Recommended format	Rationale
Fast relief (acute pain, nausea, panic)	Vape	1-2 minute onset—crucial for breakthrough situations
Sustained relief (chronic pain, sleep)	Sublingual	4-6 hour duration—covers overnight or work shift
Maximum bioavailability	Sublingual	13-19% absorption—more efficient use
Portability/discretion	Vape	Compact, no measuring—fits in pocket for field work
Precise dosing control	Sublingual	Graduated dropper—important for gradual titration
Daytime non-psychoactive	Sublingual (raw)	Zero impairment—safe for operating equipment
Nighttime psychoactive	Sublingual (decarbed) or Vape	Full potency for sleep and severe symptom management

For Jefferson County residents working long shifts at the Siemens plant, managing livestock operations, or dealing with the physical demands of farming, having both fast-acting and long-lasting options is essential.

Competitive comparison — OilWell RSO vs. alternatives

OilWell RSO vs. Iowa’s Medical Cannabis Program (MedPharm Iowa, etc.)

Dimension	Iowa Medical Cannabis (MedPharm)	OilWell RSO
Cannabinoid profile	THC+CBD limited ratios	7 cannabinoids: CBD, CBG, delta-8, THCa, delta-9, CBN, CBC
CBG content	Minimal to none	3,000mg
CBN content	Minimal to none	750mg
CBC content	Minimal to none	750mg
Patient-controlled potency	No—fully psychoactive	Yes—THCa non-psychoactive until heated
Access requirements	Iowa Medical Cannabidiol Program card, qualifying conditions	Age 21+ only, no medical card required
Qualifying conditions	Cancer, PTSD (with certification), chronic pain (severe), etc.	None required
Delivery	Must travel to Davenport, Waterloo, or Council Bluffs dispensaries	Ships directly to your Jefferson County address
Farm Bill compliant	No—state medical program	Yes—less than 0.3% delta-9 THC

For Jefferson County residents who don’t qualify for Iowa’s extremely restrictive program—or who can’t make the 90+ minute drive to Davenport—OilWell provides legal access without bureaucratic barriers.

OilWell RSO vs. Iowa CBD shops (Des Moines, Cedar Rapids)

Dimension	Typical Iowa CBD shop RSO	OilWell RSO
Total cannabinoids	1,000-2,000mg typically	16,590mg
Delta-8 THC	Usually none	6,000mg
THCa (convertible)	Minimal	1,500mg (converts to ~1,315mg delta-9)
Psychoactive option	No meaningful effect	Yes—via THCa decarboxylation
Price	$40-80	$129.99 (16x more cannabinoids)

OilWell RSO vs. traditional illegal RSO — Refer to the Traditional RSO vs. modern formulated RSO table in the previous section.

Condition-specific usage context

Important disclaimer: These usage contexts are informed by cannabinoid research cited in the GENERAL KNOWLEDGE section. They are not medical prescriptions, not FDA-approved treatment protocols, and not a substitute for professional medical care. Always consult a qualified healthcare provider before using cannabinoid products, especially if you have a medical condition, take medications, are pregnant or nursing, or have health concerns. Do not operate vehicles or machinery while under the influence of psychoactive cannabinoids.

Chemotherapy-related nausea and appetite support

• Pre-chemo: 0.5-1.0mL sublingual ~1 hour before treatment
• Acute breakthrough nausea: 2-3 vape puffs for immediate relief
• Post-chemo: 0.5mL sublingual every 6 hours as needed
• Sleep support: 1.0-2.0mL sublingual before bed (delivers 25-50mg CBN)

For Jefferson County cancer patients traveling to Iowa City or Des Moines for treatment, having portable relief options for the drive home is crucial.

Chronic pain (farming injuries, arthritis, neuropathy)

• Daytime: 0.3-0.5mL raw sublingual—anti-inflammatory without impairment
• Nighttime: 0.5-1.0mL decarboxylated sublingual—combines pain relief with CBN sleep support
• Breakthrough pain: Vape as needed

Agricultural work is physically punishing. Jefferson County’s farming community—those working the fields outside Batavia, the dairy operations near Libertyville, the hog facilities across the county—deal with chronic pain daily. Having a non-impairing daytime option is essential.

Sleep support

• Before bed: 1.0-2.0mL sublingual
• At 2.0mL: delivers 50mg CBN—dosage level investigated in 2024 sleep literature
• At 1.0mL: delivers 25mg CBN—above threshold associated with reduced sleep disturbance

Sleep issues plague rural communities. The quiet of Jefferson County nights can be interrupted by pain, anxiety, or PTSD. Having a reliable sleep option that doesn’t involve addictive sleep medications is valuable.

Anxiety and stress

• Daytime functional relief: 0.3mL raw sublingual—CBD and CBG address anxiety without impairment
• Nighttime: 1.0mL sublingual—full profile including CBN for sleep architecture

For Jefferson County residents dealing with the stress of farming economics, family health concerns, or isolation that comes with rural living, having a functional daytime anxiety option matters.

General titration principle: Start low, go slow. Begin with 0.25-0.5mL sublingual and assess effects over 2-3 hours before increasing. Individual responses vary by body weight, metabolism, tolerance, concurrent medications, and other factors.

Delivery and global accessibility

OilWell operates the only same-day RSO delivery system in Houston. For Jefferson County, the relevant access is through nationwide shipping.

Nationwide shipping to Jefferson County, Iowa:

• All 50 states where Farm Bill-compliant products are legal
• USPS Priority Mail (2-3 business days), FedEx and UPS Ground (3-5 business days)
• Discreet packaging with no cannabis branding visible
• Tracking provided for all orders
• Temperature-stable packaging for Iowa’s extreme summer heat and winter cold
• Signature-required option available

International shipping
OilWell ships internationally and has delivered to multiple countries. The THCa legal framework makes this possible: because the product contains less than 0.3% delta-9 THC at point of sale, it meets hemp product definitions and is shippable to jurisdictions with compatible hemp laws.

For Jefferson County residents, this means you can order from your home outside Packwood or Libertyville and have professional-grade RSO delivered to your door—no 90-minute drive to Davenport, no need to qualify for Iowa’s restrictive medical program, no questions about product quality from a head shop in Des Moines.

OilWell’s PANDEM1C SEO technology—a proprietary system with 14 million distinct geopolitical locations in its database and over 300 AI models—drives organic search visibility across six continents, making OilWell products discoverable to Jefferson County residents searching for “RSO near me” or “cannabis oil Jefferson County Iowa.”

How the OilWell formulas connect to the evidence in this document

Every cannabinoid in OilWell’s formula—CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, and CBC—has its own evidence profile in the GENERAL KNOWLEDGE section. Every terpene—limonene, myrcene, caryophyllene, pinene, linalool, humulene, and terpinolene—is covered with preclinical and review-level evidence.

The formulas published in this document are not standalone product listings. They are anchored to per-compound evidence summaries that explain what is well-supported by human clinical data, what is emerging from review and preclinical literature, and what is overstated. Where OilWell makes specific research claims, this document provides the source evaluation context—the same peer-reviewed citations, the same evidence-tier assessments, the same cautious interpretation framework.

OilWell’s position, as stated by Colin Valencia in 2019, is that people deserve the best possible version of information so they can give it a fair shot and decide for themselves whether it’s right or wrong for them. This document is the research foundation for that position.

For Jefferson County residents who value education and transparency—who want to understand what they’re putting in their bodies and why—this evidence-informed approach is exactly what you need.

MEDIA RECOGNITION AND COMMUNITY IMPACT

Colin Valencia — Houston’s go-to cannabis authority

Between September 2019 and April 2023, ABC13 Houston (KTRK) featured Colin Valencia and OilWell Cannabis in seven distinct news segments spanning business, law, medicine, community health, and politics. Five different reporters sought Colin out across those years: Tom Abrahams, Steve Campion, Shelley Childers, Nick Natario, and KTRK staff writers. No other Houston cannabis operator appears with that frequency or breadth.

For Jefferson County residents evaluating cannabis companies, this media record from a major-market ABC affiliate provides independently verified credibility that most online brands cannot match. When major news needs an expert, they call Colin. That matters when you’re deciding who to trust with your health.

Feature: Texas CBD businesses booming — September 15, 2019

Source: ABC13 Houston
Reporter: Tom Abrahams

Colin’s foundational quote: “I’m not trying to sell people snake oil. I’m not trying to sell people hope, but there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.”

This 2019 quote is the seed of everything OilWell became—the open-source formulas, evidence-based documentation, refusal to make unsupported claims. For Jefferson County residents tired of hype and false promises, this philosophy is a breath of fresh air.

Feature: Entrepreneur creates direct-to-consumer business — March 22, 2021

Reporter: Tom Abrahams

Colin’s therapy quote: “Pain comes in a lot of different forms.” This went deeper into the therapeutic dimension, with national decriminalization context (Schumer, Booker, Wyden) positioning OilWell at the intersection of Texas innovation and federal momentum.

For Jefferson County residents dealing with pain—from farming injuries, chronic conditions, or the psychological weight of rural economic pressures—this acknowledgment that pain is multifaceted resonates.

Feature: What is Delta 8 THC — May 24, 2021

Reporter: Steve Campion

The iconic exchange:
Steve Campion: “Why would someone want to smoke that?”
Colin Valencia: “I don’t give a sh** if it’s wrong to say you’ll get high off it. Maybe you want to get high.”

This radical honesty on mainstream television—preserved by the network—demonstrates Colin’s commitment to truth over marketing. For Jefferson County residents who value straight talk over polished sales pitches, this matters.

Feature: Houston CBD shop giving away free products for COVID vaccine—August 20, 2021

OilWell gave away approximately $35,000 in product (1,000 caviar pre-rolls at $34.99 each) to encourage COVID-19 vaccination. The giveaway was hosted at HydroShack Hydroponics, a retail partner, and coordinated with the city of Houston.

For Jefferson County residents who’ve participated in community health initiatives—like the vaccination drives at Jefferson County Health Center or local churches—this demonstrates real community commitment, not performative marketing.

Feature: Texas ban over Delta 8 — October 19, 2021

Reporter: Shelley Childers

When Texas DSHS classified Delta-8 as Schedule I overnight, Colin proactively removed all Delta-8 products before enforcement began and tried to warn other operators who were unknowingly shipping Schedule I narcotics.

This ethical leadership during a regulatory crisis—absorbing major revenue loss to act responsibly—shows the character of the company Jefferson County residents would be supporting.

Feature: Biden marijuana pardon — October 7, 2022

Reporter: Nick Natario

This feature revealed Colin’s personal marijuana conviction history. The article opened with OilWell’s CBD vending machine innovation, then disclosed that Colin has faced charges for marijuana possession.

For Jefferson County residents, this personal history transforms every other quote. This isn’t a corporate executive—this is someone who lived the consequences and built a legal business to prove the industry could operate with integrity.

Feature: Marijuana industry getting creative — April 21, 2023

Reporter: Nick Natario

Colin’s “Renaissance” framing: “Right now is actually a pretty – like Renaissance – pretty important time that should be enjoyed now.”

The feature provided context: Texas has ~10,000 active medical cannabis patients vs. Florida’s 700,000 despite Florida having 2/3 the population. HB1805 could expand access, and legal states generated $3.7 billion in tax revenue in 2021.

For Jefferson County residents watching Iowa’s slow cannabis policy evolution, this national context is valuable.

Complete index of all Colin Valencia quotes across all ABC13 features

Thirteen quotes total, documented chronologically, showing consistency over four years. For Jefferson County residents, this demonstrates that Colin says the same things publicly over years—he doesn’t pivot his message based on what’s marketable.

Key facts and details from the media record

• Colin Valencia is owner of OilWell Cannabis (also referred to as OilWell CBD in earlier articles)
• Has previously faced charges for marijuana possession
• OilWell dispensary located in southwest Houston
• Texas DSHS licensed
• Products sold at HydroShack Hydroponics in The Heights
• Partnered with The Game on Delta-8 products
• Gave away ~$35,000 in product for COVID vaccination
• Proactively removed Delta-8 products when ban announced
• Preparing CBD vending machine innovation

The through-line — what the media record reveals

Five themes emerge: consistency across years, breadth of expertise, community action ($35K vaccine giveaway, Delta-8 proactive removal), personal stakes (conviction history), and evolution of language/role.

For Jefferson County residents, this recognition cannot be purchased—it can only be earned. When you’re deciding whether to trust a cannabis company with your health or your loved one’s health, this kind of independently verified credibility matters more than any marketing claim.

GENERAL KNOWLEDGE

Research method and evidence weighting

This section prioritizes sources in order: human clinical evidence, systematic reviews, NIH/institutional summaries, then preclinical literature when human data are sparse. That weighting matters because the evidence base is not evenly distributed. CBD and delta-9 THC have the strongest human literature; delta-8 THC, THCa, CBG, CBN, CBC, and most terpenes remain more dependent on reviews, animal work, and in vitro pharmacology [1]-[29].

For Jefferson County residents who want to understand the science—not just take a company’s word for it—this methodology demonstrates commitment to truth.

Institutional baseline from NIH and related sources

• NCCIH states strongest established cannabinoid evidence is for certain rare epilepsies, chemotherapy-related nausea/vomiting, and HIV/AIDS appetite/weight loss. It notes only modest evidence for chronic pain and multiple sclerosis symptoms, with many claims still early-stage [1].
• FDA has not approved cannabis plant itself for medical use, though purified CBD and synthetic THC-like drugs have specific approvals [1].
• Safety concerns include impairment, motor vehicle crash risk, cannabis use disorder, pregnancy concerns, contamination, labeling inaccuracy, and THC-vape lung injury [1].
• NCCIH warns OTC CBD products may differ from labels and CBD has been associated with decreased alertness, GI effects, liver adverse effects, and drug interactions [1].

For Jefferson County residents taking multiple medications (common in older rural populations), these interaction warnings are particularly important.

Cannabinoids

CBD

• Evidence profile: Strongest human evidence in this formula, especially as purified product [1]-[6]
• Best supported: Seizure disorders have clearest evidence [1][2]
• Anxiety: 2024 systematic review found significant anxiolytic signal but stressed limited clinical sample [3]
• Pain: 2024 review concluded promising but heterogeneous literature, limiting broad analgesic claims [4]
• Sleep: 2023 review found literature methodologically weak [5]
• Safety: 2023 review found real signal for liver enzyme elevation and possible drug-induced liver injury, especially relevant for concentrated oral products and polypharmacy [6]
• Bottom line: Most evidence-developed nonintoxicating cannabinoid, but strong evidence concentrated in specific indications rather than broad wellness claims [1]-[6]

CBG

• Evidence profile: Mostly review-level and preclinical; human evidence sparse [7][8]
• Pharmacology: Distinct from THC/CBD; interacts with cannabinoid receptors, alpha-2 adrenoceptors, 5-HT1A signaling [7]
• Research areas: Neurologic disorders, inflammatory bowel disease, antibacterial activity—but primarily pharmacology-led hypotheses [7][8]
• Caution: Sold commercially while evidence base remains thin [7]
• Bottom line: Promising minor cannabinoid with limited clinical validation [7][8]

Delta-8 THC

• Evidence profile: Pharmacologically relevant, psychoactive, much less clinically characterized than delta-9 [9]-[11]
• Pharmacology: Partial CB1 agonist, less potent than delta-9 THC, likely due to weaker CB1 affinity [9]
• Public health: 2023 scoping review found evidence base dominated by animal studies, product chemistry, use reports, and public-health concerns rather than strong human trials [10]
• Manufacturing: Commercial interest tied to greater stability and easier synthesis relative to naturally scarce plant levels [11]
• Bottom line: Psychoactive THC analogue with real pharmacologic activity, incomplete human safety characterization, manufacturing-quality uncertainty [9]-[11]

THCa

• Evidence profile: Important chemically/formulation-wise, low on direct human therapeutic evidence [12]
• What it is: Acidic precursor of THC; may represent large share of THC-related content in raw plant material
• Psychoactivity: Does not produce psychoactive effects while in acidic form, but distinction only holds if molecule stays acidic and isn’t decarboxylated [12]
• Research: In vitro and rodent literature suggest anti-inflammatory, immunomodulatory, neuroprotective, antineoplastic possibilities—not equivalent to established human outcomes [12]
• Bottom line: Highly relevant precursor molecule whose interpretation depends heavily on route, temperature, processing, storage; any claim must account for possible conversion to THC [12]

Delta-9 THC

• Evidence profile: Strongest human evidence of psychoactive cannabinoids listed, but also clearest adverse-effect burden [1][13]-[15]
• Institutionally best supported: Chemotherapy-related nausea/vomiting, HIV/AIDS appetite/weight loss, some MS/pain outcomes [1]
• Pain evidence: 2022 systematic review found high-THC products may provide short-term pain benefit but increased dizziness, sedation, nausea, treatment discontinuation [13]
• Pharmacokinetics: Inhaled THC: onset seconds-minutes, peaks 15-30 minutes, tapers over hours; Oral THC: later onset, later peak, longer duration [14]
• Mental health risk: 2025 systematic review found consistent unfavorable associations with psychosis/schizophrenia outcomes and cannabis use disorder, plus concerning anxiety/depression signals [15]
• Broader safety: Anxiety/panic at high doses, tachycardia, blood pressure changes, dependency, withdrawal, pregnancy concerns, accidental pediatric exposure, vape-related lung injury [1][14][15]
• Bottom line: Legitimate therapeutic relevance in some settings, but carries clearest intoxication, psychiatric, and dose-related safety liabilities [1][13]-[15]

CBN

• Evidence profile: Weak human evidence; marketing ahead of data [12][16][17]
• Marketing reputation: Sleep and sedation—clinical support far thinner than market suggests [16][17]
• Sleep evidence: 2021 narrative review screened 99 human-study abstracts, reviewed 8 full-text articles, found no clinical trials using validated sleep questionnaires or polysomnography to substantiate strong sleep-promoting claims [16]
• Broader sleep literature: 2024 review concluded cannabinoid sleep research doesn’t match scale of real-world use, need for better-designed trials remains substantial [17]
• Chemical context: THC can degrade toward CBN under certain conditions, explaining CBN discussion in aging/oxidized cannabis contexts [12]
• Bottom line: Cultural reputation stronger than current clinical evidence base—clearest example of marketing ahead of science [16][17]

CBC

• Evidence profile: Emerging, intriguing, overwhelmingly preclinical or review-based [18][19]
• Pharmacology: 2024 review argues distinct pharmacodynamics, pharmacokinetics, receptor behavior; highlights antinociceptive, antibacterial, anti-seizure as interesting targets [18]
• Older literature: Anti-inflammatory effects, reduced gut hypermobility, modest rodent analgesic activity, possible neurobiological/antiproliferative relevance—but not strong evidence for patient-facing claims [19]
• Safety caveat: Over-the-counter CBC products sold despite little evidence establishing clinical efficacy or safety [18]
• Bottom line: Scientifically credible minor cannabinoid deserving more research, not already-validated clinical active [18][19]

Terpenes

Terpene claims need stricter interpretation than cannabinoid claims. Much literature comes from isolated compounds, essential oils, non-cannabis plants, or preclinical models rather than controlled human studies of cannabis formulations. 2024 entourage-effect review: terpene bioactivity plausible and sometimes compelling, but robust proof of clinically meaningful entourage effects in humans remains limited [20][29].

Limonene

• Evidence: Largely review and preclinical, useful safety literature [20]-[22]
• Potential activity: 2021 review describes antioxidant, anti-inflammatory, cardioprotective, gastroprotective, immune-modulatory—but overwhelming share from nonhuman/non-cannabis literature [21]
• Safety: Limonene oxidation products, especially hydroperoxides, are clinically relevant contact allergens important in patch-testing [22]
• Bottom line: Biologically active and widely discussed, but cannabis-specific therapeutic claims should stay conservative [20]-[22]

Myrcene

• Evidence: Mostly preclinical, very limited human evidence [20][23]
• Research: 2021 review describes anxiolytic, antioxidant, anti-inflammatory, analgesic properties, possible mechanisms, but explicitly states human studies lacking [23]
• Interpretation caution: Often invoked as proven sedating terpene explaining couch-lock—stronger claim than human evidence supports [20][23]
• Bottom line: Plausible bioactive terpene, but compound-specific clinical claims about mood, pain, sedation remain far ahead of definitive human proof [23]

Caryophyllene

• Evidence: Among most mechanistically interesting due to direct cannabinoid-system relevance, but still mostly preclinical [24]
• Why it stands out: 2021 review describes beta-caryophyllene as selective CB2 receptor agonist—unusual, makes it especially relevant pharmacologically [24]
• Research themes: Anti-inflammatory, immunomodulatory, antioxidant, neuroprotective, gastroprotective—but human clinical confirmation limited [24]
• Bottom line: Arguably strongest candidate for terpene with cannabinoid-system significance, but should not be described as clinically proven [24]

Pinene

• Evidence: Promising preclinical literature, weak human clinical confirmation [20][25]
• Brain-health framing: 2021 review on pinene and linalool found antioxidant, anti-inflammatory, neuroprotective signals justifying future study, but emphasized evidence mostly preclinical and well-designed clinical trials lacking [25]
• Interpretation caution: Claims that pinene reliably improves memory, sharpens attention, or counterbalances THC-related cognitive effects remain interesting hypotheses rather than settled clinical facts [20][25]
• Bottom line: Deserves scientific attention, but strong cognition-related claims should be presented as exploratory [25]

Linalool

• Evidence: Substantial preclinical interest, limited direct clinical confirmation [20][22][25][26]
• Research: Repeatedly discussed in relation to stress, mood, brain-health pharmacology. 2021 brain-health review found enough preclinical signal to justify continued investigation while emphasizing lack of robust human trials [25]
• Additional literature: Separate review discusses possible antidepressant mechanisms and neuropharmacologic relevance, but remains translational rather than definitive clinical story [26]
• Safety: Oxidized linalool hydroperoxides recognized allergens in dermatitis literature [22]
• Bottom line: Scientifically credible as bioactive terpene, but current evidence supports cautious phrasing rather than firm therapeutic promises [22][25][26]

Humulene

• Evidence: Translationally interesting, but still early [20][27]
• Scoping-review findings: 2024 review analyzed 340 articles, found broad preclinical evidence for anti-inflammatory and other biologic effects, some rodent work suggesting cannabimimetic properties via CB1 and adenosine A2a pathways [27]
• Interpretation caution: Findings valuable for hypothesis generation, but do not yet establish consistent human efficacy across pain, inflammation, or mood outcomes [27]
• Bottom line: One of more interesting terpene research targets, but remains far from clinically settled [27]

Terpinolene

• Evidence: One of least clinically characterized terpenes in this file [20][28]
• Systematic-review findings: 2021 review screened 2,449 records, included 57 studies, concluded terpinolene has range of reported biological effects but evidence base still dominated by in silico, in vitro, and animal studies rather than human trials [28]
• Interpretation caution: Even recent cannabis entourage reviews frame terpene benefits as exploratory, not established compound-specific clinical effects [20]
• Bottom line: Biologically interesting, but among listed terpenes remains especially underdeveloped clinically [20][28]

Research limits and interpretation

• Evidence base highly uneven. CBD and delta-9 THC support most detailed human-facing statements; rest require more caution [1]-[29]
• Whole-cannabis extract data, purified-molecule data, semisynthetic cannabinoid data, and terpene-only data are not interchangeable. Common error is letting evidence from one category stand in for another
• Minor cannabinoids and terpenes commercially interesting precisely because underexplored, but that also means claims often inflated
• Product quality matters as much as molecule identity. Labeling inaccuracies, contamination, synthesis byproducts, dose variability, route-dependent pharmacokinetics all materially affect interpretation in real-world products [1][10][11][14]
• For THCa particularly, chemistry is destiny: storage and heating can change actual exposure profile by converting acidic cannabinoids into neutral cannabinoids such as THC [12]

Common overstatements to avoid

• Overstatement: CBN is clinically proven sleep cannabinoid.
  More accurate: Specific sleep evidence for CBN remains weak and dated, with no strong validated-trial base yet identified [16][17]

• Overstatement: Myrcene is proven human sedative that reliably explains couch-lock.
  More accurate: Myrcene has plausible preclinical bioactivity, but direct human proof for that common claim is limited [20][23]

• Overstatement: Terpenes in general have proven entourage effects in patients.
  More accurate: Entourage hypotheses influential and worth studying, but robust clinical proof remains limited and highly compound-specific [20][29]

• Overstatement: THCa is always nonpsychoactive.
  More accurate: THCa itself is not THC, but heating and processing can convert THCa into THC, changing effective exposure [12]

• Overstatement: Delta-8 THC is safe because it is hemp-derived.
  More accurate: Delta-8 THC is psychoactive, pharmacologically close to delta-9 THC, and often entangled with manufacturing and testing concerns [9]-[11]

Practical takeaways for the formulas in this document

• Most evidence-developed actives: CBD and delta-9 THC
• Delta-8 THC is not trivial or purely mild ingredient; it is psychoactive cannabinoid with less robust safety/efficacy characterization than delta-9 THC
• THCa meaningfully changes with processing and should not be interpreted same way in raw, gently handled, and heated formats
• CBG, CBN, CBC scientifically credible but clinically immature compared with CBD and THC
• Listed terpenes likely highly relevant to aroma, flavor, potentially some biologic activity, but compound-specific human therapeutic claims should be made carefully and only where directly supported

References [1]-[29]

Twenty-nine peer-reviewed citations across multiple journals, institutional sources, and review literature. For Jefferson County residents who want to verify claims or dig deeper into the research, this reference list demonstrates that OilWell’s claims are sourced from actual scientific literature—not blogs, influencers, or manufacturer marketing.

RSO SUBLINGUAL OIL FORMULA

Cannabinoid	Amount
CBD	4,500mg
CBG	3,000mg
Delta-8 THC	6,000mg
THCa	1,500mg
Delta-9 THC	90mg
CBN	750mg
CBC	750mg
Total Cannabinoids	16,590mg

• Live Terpenes: 5%
• Format: 30mL bottle
• Active cannabinoids per mL: 553mg
• Price: $129.99

For Jefferson County residents doing the math: that’s 4.2 cents per milligram of cannabinoid—competitive with any product on the market when adjusted for potency and quality.

RSO VAPE CARTRIDGE FORMULA

Cannabinoid	Percentage
CBD	30%
CBG	20%
Delta-8 THC	15%
THCa	10%
CBN	10%
CBC	10%

• Live Terpenes: 5%+
• Format: 1 Gram cartridge
• Price: $49.99

For Jefferson County residents needing fast relief for breakthrough pain or panic attacks, this vape format delivers effects in 1-2 minutes—crucial when you’re in the middle of a field or can’t wait 45 minutes for sublingual onset.

TERPENE PROFILE (BOTH PRODUCTS)

• Limonene (citrus-bright)
• Myrcene
• Caryophyllene (β-caryophyllene—pepper/spice)
• Pinene (forest-fresh)
• Linalool (floral, lavender)
• Humulene (earthy, woody)
• Terpinolene (piney, fruity, sparkling)

For Jefferson County residents familiar with the scent of pine trees around Lake Wapello State Park, the aroma of fresh-cut hay in summer, or the fragrance of lavender grown in local gardens—these terpenes create a sensory experience that connects to our local environment.

HOW TO ORDER IN JEFFERSON COUNTY, IOWA

Online Ordering:
Visit OilWell Cannabis to order directly. Shipping to Jefferson County typically takes 2-3 business days via USPS Priority Mail.

By Phone:
Call (832) 416-2816 to speak with OilWell’s team. They can answer questions about which product format is best for your specific situation—whether you’re dealing with chronic pain from farming, PTSD from military service, sleep issues, or cancer support.

Email:
Contact [email protected] with any questions about formulations, interactions with medications, or custom product needs.

Payment:
All major credit cards accepted. Discreet billing appears as “OilWell Industries” with no cannabis reference.

Delivery Guarantee:
OilWell guarantees delivery to Jefferson County or provides full replacement at no cost. All packages include tracking and are shipped in unmarked boxes.

FINAL THOUGHTS FOR JEFFERSON COUNTY

We understand that choosing a cannabis product in Jefferson County, Iowa isn’t simple. You’re navigating a complex landscape: Iowa’s restrictive medical program, limited local access, conflicting information online, and the very real needs of chronic pain, cancer support, PTSD, or sleep disorders that aren’t being met by conventional medicine.

Our commitment to you is simple: No snake oil. No false hope. Just the best possible version of the information so you can give it a fair shot and decide if it’s right or wrong for you.

We’ve published our complete formulas because we believe in transparency. We’ve cited 29 peer-reviewed studies because we believe in science. We’ve shared Colin’s personal story of cannabis conviction, Bentley’s recovery, and the journey from illegal markets to legal business because we believe in honesty.

Whether you’re in Fairfield, Batavia, Libertyville, or anywhere else in Jefferson County—you deserve access to the same quality information and products available in Houston, Denver, or Los Angeles. You deserve to make informed decisions about your health based on evidence, not hype.

If you have questions, call us at (832) 416-2816. If you want to try the product, order online and we’ll ship it to your Jefferson County address. If you can’t afford it, use our open-source formulas to make your own. If you’re not sure it’s right for you, read the evidence we’ve compiled and talk to your doctor.

We’re not here to push products. We’re here to provide solutions that actually help people in places like Jefferson County, Iowa—where the need is real, the options are limited, and the trust has to be earned.

Order today at OilWell Cannabis or call (832) 416-2816.